Untangling Psychology from Biology in the Treatment of Psychiatric Disorders

Authors

  • Michael Raymond Binder, M.D

Keywords:

psychotherapy, medication, biomarkers, mind-brain dynamics, neuronal hyperexcitability

Abstract

Due to the lack of a clear distinction between mentally-driven psychiatric symptoms and neurologically-driven psychiatric symptoms, determining which patients would best be treated with psychotherapy, which patients would best be treated with pharmacotherapy, and which patients would best be treated with both is a challenge that every behavioral health clinician faces. In an effort to overcome this challenge, this article will discuss the anatomical and functional relationship between the mind and the brain as it relates to the various treatment options that are currently available and introduce a groundbreaking new paradigm that is destined to transform the treatment of mental illness from a symptom-based practice to a pathology-based practice.

Downloads

How to Cite

Untangling Psychology from Biology in the Treatment of Psychiatric Disorders. (2023). Global Journal of Medical Research, 23(A3), 1-16. https://doi.org/10.34257/GJMRAVOL23IS3PG1

References

T Insel, P Wang (2009) The STAR*D trial: Revealing the need for better treatments.

S Saxena, E Gorbis, J O'neill, S Baker, M Mandelkern, K Maidment, S Chang, N Salamon, A Brody, J Schwartz, E London (2009) Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. 14(2), 197-205.

Asimina Lazaridou, Jieun Kim, Christine Cahalan, Marco Loggia, Olivia Franceschelli, Chantal Berna, Peter Schur, Vitaly Napadow, Robert Edwards (2017) Effects of Cognitive-Behavioral Therapy (CBT) on Brain Connectivity Supporting Catastrophizing in Fibromyalgia. 33(3), 215-221.

R Hirschfeld (2000) History and evolution of the monoamine hypothesis of depression. 61(6), 4-6.

R Strawbridge, R Javed, J Cave, S Jauhar, A Young (2022) The effects of reserpine on depression: A systemic review.

A Neumeister, A Nugent, T Waldeck (2004) Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. 61, 765-773.

Rif El-Mallakh, Paul Vöhringer, Michael Ostacher, Claudia Baldassano, Niki Holtzman, Elizabeth Whitham, Sairah Thommi, Frederick Goodwin, S Ghaemi (2015) Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial. 184, 318-321.

Joseph Goldberg, Christine Truman (2001) Antidepressant‐induced mania: an overview of current controversies. 5(6), 407-420.

Christine Truman, Joseph Goldberg (2007) Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use. 68(10), 1472-1479.

Chantal Henry, Frederic Sorbara, Jerome Lacoste, Claire Gindre, Marion Leboyer (2001) Antidepressant-Induced Mania in Bipolar Patients: Identification of Risk Factors. 62(4), 249-255.

M Binder (2022) Mind-brain dynamics in the pathophysiology of psychiatric disorders. 10(2), 48-62.

Andrew Krystal (2010) Antidepressant and Antipsychotic Drugs. 5(4), 571-589.

Joshua Gittelman, David Perkel, Christine Portfors (2013) Dopamine Modulates Auditory Responses in the Inferior Colliculus in a Heterogeneous Manner. 14(5), 719-729.

W Löscher, D Schmidt (1980) Increase of Human Plasma GABA by Sodium Valproate. 21(6), 611-615.

Rod Edwards, Una Stephenson, Tom Flewett (1991) Clonazepam in Acute Mania: A Double Blind Trial. 25(2), 238-242.

Rif El-Mallakh, Mary Huff (2001) Mood Stabilizers and Ion Regulation. 9(1), 23-32.

Epolia Ramadan, Mireille Basselin, Jagadeesh Rao, Lisa Chang, Mei Chen, Kaizong Ma, Stanley Rapoport (2012) Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder. 15(07), 931-943.

D Newport, Linda Carpenter, William Mcdonald, James Potash, Mauricio Tohen, Charles Nemeroff (2015) Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression. 172(10), 950-966.

Abby Pribish, Nicole Wood, Arun Kalava (2020) A Review of Nonanesthetic Uses of Ketamine. 2020, 1-15.

S Kanes, H Colquhoun, H Gunduz-Bruce (2017) Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. 390(10093), 480-489.

H Gunduz-Bruce, C Silber, I Kaul (2019) Trial of SAGE-217 in patients with major depressive disorder. 381(10), 903-911.

Kristina Deligiannidis, Samantha Meltzer-Brody, Handan Gunduz-Bruce, James Doherty, Jeffrey Jonas, Sigui Li, Abdul Sankoh, Christopher Silber, Andrew Campbell, Brian Werneburg, Stephen Kanes, Robert Lasser (2021) Effect of Zuranolone vs Placebo in Postpartum Depression. 78(9), 951.

Fred Lado, Solomon Moshé (2008) How do seizures stop?. 49(10), 1651-1664.

Virginie Lambrecq, Frédéric Villéga, Cécile Marchal, Véronique Michel, Dominique Guehl, Jean-Yves Rotge, Pierre Burbaud (2012) Refractory status epilepticus: Electroconvulsive therapy as a possible therapeutic strategy. 21(9), 661-664.

Hooman Kamel, Susannah Cornes, Manu Hegde, Stephen Hall, S Josephson (2010) Electroconvulsive Therapy for Refractory Status Epilepticus: A Case Series. 12(2), 204-210.

I Salik, R Marwaha (2022) Electroconvulsive therapy.

Roman Gersner, Elena Kravetz, Jodie Feil, Gaby Pell, Abraham Zangen (2011) Long-Term Effects of Repetitive Transcranial Magnetic Stimulation on Markers for Neuroplasticity: Differential Outcomes in Anesthetized and Awake Animals. 31(20), 7521-7526.

Nadia García-Medina, María Miranda (2013) Nucleus of the solitary tract chemical stimulation induces extracellular norepinephrine release in the lateral and basolateral amygdala. 6(2), 198-201.

J Lynch (2020) Stellate ganglion block treats posttraumatic stress: An example of precision mental health. 10(11), 1807.

Sam Parnia, K Spearpoint, G De Vos (2014) Reply letter to: Letter to the editor Parnia, Sam et al. AWARE - Awareness during resuscitation - A prospective study. 97, e15.

B Greyson (2021) After: A doctor explores what near-death experiences reveal about life and beyond.

Van Lommel, P (2010) Review of the book Consciousness beyond life: The science of the near-death experience, by P. van Lommel..

R Moody (1975) Life after life.

P Fenwick, E Fenwick (2008) Review of the book The art of dying, by P. Fenwick and E. Fenwick..

Bruce Greyson, Edward Kelly, Wjr Dunseath (2013) Surge of neurophysiological activity in the dying brain. 110(47), 4405.

Sam Parnia, Stephen Post, Matthew Lee, Sonja Lyubomirsky, Tom Aufderheide, Charles Deakin, Bruce Greyson, Jeffrey Long, Anelly Gonzales, Elise Huppert, Analise Dickinson, Stephan Mayer, Briana Locicero, Jeff Levin, Anthony Bossis, Everett Worthington, Peter Fenwick, Tara Shirazi (2022) Guidelines and standards for the study of death and recalled experiences of death--a multidisciplinary consensus statement and proposed future directions. 1511(1), 5-21.

Moran Cerf, Nikhil Thiruvengadam, Florian Mormann, Alexander Kraskov, Rodrigo Quiroga, Christof Koch, Itzhak Fried (2010) On-line, voluntary control of human temporal lobe neurons. 467(7319), 1104-1108.

Wilder Penfield (1936) EPILEPSY AND SURGICAL THERAPY. 36(3), 449.

D Purves, G Augustine, D Fitzpatrick (2001) Neuroscience.

Björn Merker (2007) Consciousness Without a Cerebral Cortex††"Consciousness without a cerebral cortex: A challenge for neuroscience and medicine" by Björn Merker appeared in Behavioral and Brain Sciences 30:63-81 (2007). Reprinted with kind permission of Cambridge University Press.. 30, 193-230.

K Kawkabani (2018) Preserved consciousness in the absence of a cerebral cortex, the legal and ethical implications of redefining consciousness and its neural correlates: A case for a subcortical system generating affective consciousness. 734.

B Theyel, D Llano, S Sherman (2010) The corticothalamocortical circuit drives higher-order cortex in the mouse. 13, 84-88.

J Posner, F Plum (2007) Plum and Posner's Diagnosis of Stupor and Coma. 4, 401.

N Schiff, J Giacino, K Kalmar, J Victor, K Baker, M Gerber, B Fritz, B Eisenberg, J O'connor, E Kobylarz, S Farris, A Machado, C Mccagg, F Plum, J Fins, A Rezai (2007) Behavioural improvements with thalamic stimulation after severe traumatic brain injury. 448(7153), 600-603.

Jean‐jacques Lemaire, Anna Sontheimer, Bruno Pereira, Jérôme Coste, Sarah Rosenberg, Catherine Sarret, Guillaume Coll, Jean Gabrillargues, Betty Jean, Thierry Gillart, Aurélien Coste, Basile Roche, Antony Kelly, Bénédicte Pontier, Fabien Feschet (2018) Deep brain stimulation in five patients with severe disorders of consciousness. 5(11), 1372-1384.

Robert Derubeis, Greg Siegle, Steven Hollon (2008) Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. 9(10), 788-796.

M Binder (2019) The Multi-Circuit Neuronal Hyperexcitability Hypothesis of Psychiatric Disorders. 7(1), 12.

Mar Ferreira, O 'donovan, M Sklar, P (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. 40(9), 1056-1058.

Aihua Yuan, Zhenghui Yi, Qiang Wang, Jinhua Sun, Zhiqiang Li, Yasong Du, Chen Zhang, Tao Yu, Juan Fan, Huafang Li, Shunying Yu (2012) ANK3 as a risk gene for schizophrenia: New data in han Chinese and meta analysis. 159B(8), 997-1005.

E Green, D Grozeva, I Jones, L Jones, G Kirov, S Caesar, K Gordon-Smith, C Fraser, L Forty, E Russell, M Hamshere, V Moskvina, I Nikolov, A Farmer, P Mcguffin, P Holmans, M Owen, M O'donovan, N Craddock (2010) The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. 15(10), 1016-1022.

A Lopez, X Wang, M Xu (2017) Ankyrin-G isoform imbalance and interneuronopathy link epilepsy and bipolar disorder. 22(10), 1464-1472.

J Gargus (2006) Ion channel function candidate genes in multigenic neuropsychiatric disease. 60, 177-185.

Y Liu, D Blackwood, S Caesar (2011) SEX-STRATIFIED GENOME-WIDE ASSOCIATION META-ANALYSIS OF MAJOR DEPRESSIVE DISORDER. 99(1), 31.

Z Iqbal, G Vandeweyer, M Van Der Voet, A Waryah, M Zahoor, J Besseling, L Roca, A Vulto-Van Silfhout, B Nijhof, J Kramer, N Van Der Aa, M Ansar, H Peeters, C Helsmoortel, C Gilissen, L Vissers, J Veltman, A De Brouwer, R Frank Kooy, S Riazuddin, A Schenck, H Van Bokhoven, L Rooms (2013) Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders. 22(10), 1960-1970.

Jaichandar Subramanian, Louis Dye, Alexei Morozov (2013) Rap1 Signaling Prevents L-Type Calcium Channel-Dependent Neurotransmitter Release. 33(17), 7245-7252.

Mónica Santos, Davide D'amico, Ornella Spadoni, Alejandro Amador-Arjona, Oliver Stork, Mara Dierssen (2013) Hippocampal Hyperexcitability Underlies Enhanced Fear Memories in TgNTRK3, a Panic Disorder Mouse Model. 33(38), 15259-15271.

Anis Contractor, Vitaly Klyachko, Carlos Portera-Cailliau (2015) Altered Neuronal and Circuit Excitability in Fragile X Syndrome. 87(4), 699-715.

Niamh O'brien, Michael Way, Radhika Kandaswamy, Alessia Fiorentino, Sally Sharp, Giorgia Quadri, Jarram Alex, Adebayo Anjorin, David Ball, Raquin Cherian, Karim Dar, Aynur Gormez, Irene Guerrini, Mathis Heydtmann, Audrey Hillman, Sudheer Lankappa, Greg Lydall, Aideen O'kane, Shamir Patel, Digby Quested, Iain Smith, Allan Thomson, Nicholas Bass, Marsha Morgan, David Curtis, Andrew Mcquillin (2014) The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder. 24(6), 277-278.

S Ripke, B Neale, O'donovan Mc (2014) Biological insights from 108 schizophrenia-associated genetic loci. 511(7510), 421-427.

R Freedman, H Coon, Myles Worsley, M (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. 94(2), 587-592.

Rocco Pizzarelli, Enrico Cherubini (2011) Alterations of GABAergic Signaling in Autism Spectrum Disorders. 2011, 1-12.

T Johnstone, C Van Reekum, H Urry, N Kalin, R Davidson (2007) Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. 27(33), 8877-8884.

Andrew Leuchter, Ian Cook, Aimee Hunter, Chaochao Cai, Steve Horvath (2012) Resting-State Quantitative Electroencephalography Reveals Increased Neurophysiologic Connectivity in Depression. 7(2), e32508.

G Rose, D Diamond, K Pang, T Dunwiddie (1988) Primed Burst Potentiation: Lasting Synaptic Plasticity Invoked by Physiologically Patterned Stimulation. 96-98.

E Hargreave (2006) The neuroplasticity phenomenon of kindling.

Anika Guha, Cindy Yee, Wendy Heller, Gregory Miller (2012) Alterations in the default mode‐salience network circuit provide a potential mechanism supporting negativity bias in depression. 58(12).

M Binder (2021) The neuronal excitability spectrum: A new paradigm in the diagnosis, treatment, and prevention of mental illness and its relation to chronic disease. 9(6), 187-203.

A Henkel, O Welzel, T Groemer (2010) Fluoxetine prevents stimulation-dependent fatigue of synaptic vesicle exocytosis in hippocampal neurons. 114(3), 697-705.

Sverre Varvin (2014) Which patients should avoid psychoanalysis, and which professionals should avoid psychoanalytic training?. 26(2), 109-122.

Gin Malhi, Erica Bell, Darryl Bassett, Philip Boyce, Richard Bryant, Philip Hazell, Malcolm Hopwood, Bill Lyndon, Roger Mulder, Richard Porter, Ajeet Singh, Greg Murray (2021) The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. 55(1), 7-117.

M Binder (2021) A pathophysiolgically-based approach to the treatment and prevention of mental illness and its related disorders. 9(6), 223-232.

Bhumika Shah, O Elsayed, R El-Mallakh (2023) Bipolar disorder: The foundational role of mood stabilizers. 22(5), 36-41.

E Weitz, S Hollon, J Twisk (2015) Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: an individual patient data metaanalysis. 72, 1102-1109.

P Cuijpers, De Wit, L Weitz, E (2015) The combination of psychotherapy and pharmacotherapy in the treatment of adult depression: a comprehensive meta-analysis. 15, 147-168.

E Khedr, Y Elserogy, M Fawzy (2020) Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study. 291, 113287.

B Godlewska, R Norbury, S Selvaraj, P Cowen, C Harmer (2012) Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients. 42(12), 2609-2617.

D Hett, S Marwaha (2020) Repetitive transcranial magnetic stimulation in the treatment of bipolar disorder. 18(10).

Taylor Marzouk, Stephanie Winkelbeiner, Heela Azizi, Anil Malhotra, Philipp Homan (2020) Transcranial Magnetic Stimulation for Positive Symptoms in Schizophrenia: A Systematic Review. 79(6), 384-396.

M Binder (2022) Neuronal hyperexcitability: The elusive but modifiable instigator of disease. 10(1), 1-7.

Hcr Grunze (2008) The effectiveness of anticonvulsants in psychiatric disorders. 10(1), 77-89.

O Yizhar, L Fenno, M Prigge (2011) Neocortical excitation/inhibition balance in information processing and social dysfunction. 477, 171-178.

M Binder (2019) Electrophysiology of seizure disorders may hold key to the pathophysiology of psychiatric disorders. 7(5), 103-110.

M Binder (2021) Neuronal hyperexcitability: significance, cause, and diversity of clinical expression. 9(5), 157-167.

M Binder (2022) Suicide: A new hypothesis on the pathogenesis of disease, method of screening, and means of prevention. 10(3), 111-124.

M Macpherson, M De Groh, L Loukine, D Prud'homme, L Dubois (2009) Prevalence of metabolic syndrome and its risk factors in Canadian children and adolescents: Canadian Health Measures Survey Cycle 1 (2007-2009) and Cycle 2 (2009-2011). 36(2), 32-40.

L Wallis, M Healy, M Unde, I Maconochi (2005) Age related reference ranges for respiration rate and heart rate from 4 to 16 years. 90(11), 1117-1121.

M Binder (2021) Gabapentin-The popular but controversial anticonvulsant drug may be zeroing in on the pathophysiology of disease. 9(4), 122-134.

L Young (2008) What is the best treatment for bipolar depression?. 33(6), 487-488.

A Lubloy, J Kereszturi, A Nemeth, P Mihalicza (2020) Exploring factors of diagnostic delay for patients with bipolar disorder: a population-based cohort study. 20(75).

Jessica Dagani, Giulia Signorini, Olav Nielssen, Moira Bani, Adriana Pastore, Giovanni Girolamo, Matthew Large (2016) Meta-analysis of the Interval between the Onset and Management of Bipolar Disorder. 62(4), 247-258.

R Hirschfeld, L Lewis, L Vornik (2003) Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 survey of individuals with bipolar disorder. 64(2), 161-174.

D Campbell (2012) People with bipolar disorder may wait 13 years for diagnosis.

Antti Latvala, Ralf Kuja-Halkola, Christian Rück, Brian D'onofrio, Tomas Jernberg, Catarina Almqvist, David Mataix-Cols, Henrik Larsson, Paul Lichtenstein (2016) Association of Resting Heart Rate and Blood Pressure in Late Adolescence With Subsequent Mental Disorders. 73(12), 1268.

E Blom, E Serlachius, M Chesney, Emg Olsson (2014) Adolescent girls with emotional disorders have a lower end-tidal CO2 and increased respiratory rate compared with healthy controls. 51(5), 412-418.

L Colangelo, Y Yano, Jacobs Jr, D, Lloyd-Jones Dm (2020) Association of resting heart rate with blood pressure and incident hypertension over 30 years in black and white adults: The CARDIA study. 76(3), 692-698.

Yuanyuan Shi, Wen Zhou, Xuejiao Liu, Zhiguang Ping, Yu-Qian Li, Chongjian Wang, Jie Lu, Zhen-Xing Mao, Jingzhi Zhao, Lei Yin, Dongdong Zhang, Linlin Li (2018) Resting heart rate and the risk of hypertension and heart failure. 36(5), 995-1004.

Lijun Shen, Yuming Wang, Xuesong Jiang, Yongcheng Ren, Chengyi Han, Yongguang Yang (2020) Dose-response association of resting heart rate and hypertension in adults. 99(10), e19401.

Jamshed Dalal, Arup Dasbiswas, Immaneni Sathyamurthy, Srinivasa Maddury, Prafulla Kerkar, Sandeep Bansal, Joy Thomas, Sankar Mandal, Soura Mookerjee, Sivakadaksham Natarajan, Viveka Kumar, Nishith Chandra, Aziz Khan, R Vijayakumar, J Sawhney (2019) Heart Rate in Hypertension: Review and Expert Opinion. 2019, 1-6.

D Lee, Lfm De Rezende, F Hu, J Jeon, E Giovannucci, B Hartaigh, L Vatten (2015) Resting heart rate and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies. 35(2), 101.

T Nagaya, H Yoshida, H Takahashi, M Kawai (2010) Resting heart rate and blood pressure, independent of each other, proportionally raise the risk for type-2 diabetes mellitus. 39(1), 102.

W Kannel, C Kannel, R Paffenbarger, A Cupples (1987) Heart rate and cardiovascular mortality: The Framingham study. 113, 103.

Richard Gillum, Diane Makuc, Jacob Feldman (1991) Pulse rate, coronary heart disease, and death: The NHANES I Epidemiologic Follow-up Study. 121(1), 172-177.

Marie Cooney, Erkki Vartiainen, Tinna Laakitainen, Anne Juolevi, Alexandra Dudina, Ian Graham (2010) Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. 159(4), 612-619.e3.

Hassan Khan, Setor Kunutsor, Andreas Kalogeropoulos, Vasiliki Georgiopoulou, Anne Newman, Tamara Harris, Kirsten Bibbins‐domingo, Jussi Kauhanen, Mihai Gheorghiade, Gregg Fonarow, Stephen Kritchevsky, Jari Laukkanen, Javed Butler (2015) Resting Heart Rate and Risk of Incident Heart Failure: Three Prospective Cohort Studies and a Systematic Meta‐Analysis. 4(1), 1364-001106.

L Alhalabi, M Singleton, A Oseni (2017) Relation of higher resting heart rate to risk of cardiovascular versus noncardiovascular death. 119(7), 107.

Dongfeng Zhang, Xiaoli Shen, Xin Qi (2016) Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis. 188(3), E53-E63.

Junxing Yu, Liye Dai, Quanhui Zhao, Xiaoxue Liu, Shuohua Chen, Anxin Wang, Zhaoping Su, Shouling Wu (2017) Association of Cumulative Exposure to Resting Heart Rate with Risk of Stroke in General Population: The Kailuan Cohort Study. 26(11), 2501-2509.

Y-Q Huang, G Shen, J-Y Huang, B Zhang, Y-Q Feng (2020) A nonlinear association between resting heart rate and ischemic stroke among community elderly hypertensive patients. 132(2), 110.

D Aune, A Sen, B Ó'hartaigh, I Janszky, P Romundstad, S Tonstad, L Vatten (2017) Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies. 27(6), 504-517.

Markus Anker, Nicole Ebner, Bert Hildebrandt, Jochen Springer, Marianne Sinn, Hanno Riess, Stefan Anker, Ulf Landmesser, Wilhelm Haverkamp, Stephan Von Haehling (2016) Resting Heart Rate is an Independent Predictor of Death in Patients with Colorectal, Pancreatic, and Non-Small Cell Lung Cancer: Results of a Prospective Cardiovascular Long-Term Study. 18(12), 1524-1534.

J Park, J Kim, Y ; Park, S Burke (2018) Resting heart rate moderates the relationship between neuropsychiatric symptoms, MCI, and Alzheimer's disease. 13(3), 641-114.

X Jouven, J-P Empana, P Schwartz (2005) Psychiatric and functional physical symptoms: the more telling "fifth" vital sign. 352(6), 117.

M Binder, M Binder (2012) Anticonvulsants: The psychotropic and medically protective drugs of the future. 9(5), 66-70.

Untangling Psychology from Biology in the Treatment of Psychiatric Disorders

Published

2023-08-02

How to Cite

Untangling Psychology from Biology in the Treatment of Psychiatric Disorders. (2023). Global Journal of Medical Research, 23(A3), 1-16. https://doi.org/10.34257/GJMRAVOL23IS3PG1